TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PCI Biotech Holding ASA
Closing information (x1000 NOK)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 9,392 | 9,585 | 10,250 |
Financial expenses | 2,680 | 151 | 87 |
Earnings before taxes | -88,746 | -34,780 | -42,841 |
Total assets | 282,032 | 357,056 | 58,436 |
Current assets | 275,749 | 357,039 | 58,414 |
Current liabilities | 24,627 | 16,995 | 14,585 |
Equity capital | 254,829 | 339,954 | 41,842 |
- share capital | 111,797 | 111,494 | 74,961 |
Employees (average) | 0 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 90.4% | 95.2% | 71.6% |
Turnover per employee | |||
Profit as a percentage of turnover | -944.9% | -362.9% | -418.0% |
Return on assets (ROA) | -30.5% | -9.7% | -73.2% |
Current ratio | 1119.7% | 2100.8% | 400.5% |
Return on equity (ROE) | -34.8% | -10.2% | -102.4% |
Change turnover | -193 | -665 | -225 |
Change turnover % | -2% | -6% | -2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.